Global NTM Infections Pipeline Poised for Growth as Breakthrough Therapies Advance Toward Late-Stage Development, states DelveInsight

Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...
Farmers Weekly Interactive

How Johne’s management cut disease to less than 2% of herd

Consistent efforts to prevent Johne’s disease in a high-yielding Wiltshire dairy herd have resulted in cases falling from a ...
MPR

MannKind Ends Trial of Nebulized Clofazimine for NTM Lung Disease

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
The Manila Times

MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease

MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Emerging infections you should know about and how to prevent them

The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health threats, experts say.
TechRadar

Even the most complex and advanced business VPN tools could still leave you at risk of attack - here's how to stay safe

Report finds VPN complexity and poor maintenance driving surge in ransomware incidents Cloud-based VPN alternatives can lower exposure to ransomware and direct attacks Complex on-premise VPN systems ...